Visible Spectrophotometric and Thermodynamic Studies of Diclofenac: Charge-Transfer Complexation with 2, 3 Dichloro-5, 6-dicyano, 1, 4-benzoquinone by Uzochukwu, IC & Nzegbunam, SO
Uzochukwu & Nzegbunam 
Trop J Pharm Res, March 2015; 14(3): 519  
 
Tropical Journal of Pharmaceutical Research March 2015; 14 (3): 519-525 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v14i3.22 
Original Research Article 
 
 
Visible Spectrophotometric and Thermodynamic Studies of 
Diclofenac: Charge-Transfer Complexation with 2, 3 
Dichloro-5, 6-dicyano, 1, 4-benzoquinone 
 
Ikemefuna C Uzochukwu* and Stanley O Nzegbunam  
Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, PMB 
5025, Awka 420281, Nigeria 
 
*For correspondence: Email: ic.uzochukwu@unizik.edu.ng; Tel: +234 8035476925 
 
Received: 29 June 2014        Revised accepted: 12 January 2015 
 
Abstract 
Purpose: To investigate the visible spectrophotometric and thermodynamic parameters of diclofenac 
with regard to charge-transfer complexation with 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone. 
Methods: The wavelength of maximum absorption, stoichiometry, time-absorbance relationship, effect 
of pH, Beer’s plot and Beer’s law limit for the complex were evaluated for diclofenac. In order to validate 
an assay method based on the complexation reaction, the limit of detection and quantitation, precision, 
accuracy and selectivity were determined. The developed assay method was applied to the assay of 
diclofenac tablet and capsule brands.  
Results: A 1:1 complex that absorbed maximally at 506 nm and a Beer’s plot with a regression 
coefficient of 0.9970 ± 0.0010 were obtained. Beer’s law was obeyed in the concentration range of 
0.0017 to 0.2111 mg/ml and precision was within acceptable limits. The limits of detection and of 
quantitation of the method was 0.000801 and 0.002426 mg/ml, respectively. The spontaneity of the 
complexation reaction was demonstrated by negative Gibb’s free and positive entropy energy changes. 
The drug content of commercial diclofenac products to which the assay method was applied was 
between 94 and 102 %.  
Conclusion: Charge-transfer complexation of diclofenac with 2, 3-dichloro-5, 6-dicyano-1, 4-
benzoquinone is straightforward, and the assay method based on it is simple and robust for the 
determination of diclofenac in tablet or capsule formulation. 
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Diclofenac sodium, 2-[2, (6-dichlorophenyl)-
amino] benzene acetic acid monosodium salt, is 
a non-steroidal anti-inflammatory drug with 
potent activity and outstanding tolerability, and is 
used as an analgesic, antipyretic and anti-
inflammatory agent [1].  
 
Formulations of diclofenac have been assessed 
by ultraviolet spectrophotometry [2,3], 
spectrofluorimetry [4], flow extraction 
spectrophotometry [5], Raman spectroscopy [6], 
and gas-liquid chromatography for biological 
fluids [7-9]. Molecular spectroscopic methods 
based upon the formation of ion-pairs [10-12] 
have also been reported. Non-aqueous titration 
with perchloric acid and reversed phase HPLC 
method are recommended in the British 
Pharmacopeia for diclofenac pure form and 
tablets respectively [13].  
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HPLC methods have suffered from such 
challenges as long analysis time, large 
consumption of solvents and reagents, high cost, 
complicated routine maintenance, ease of use 
and large dimension [14]. Simple, cheap and 
accurate assay methods are desirable for routine 
quality control of pharmaceuticals, especially in 
resource-poor countries. Spectrophotometry is 
the most widely used technique in 
pharmaceutical analysis because of its inherent 
simplicity and wide availability in most quality 
control laboratories [15].  
 
Literature survey revealed that charge transfer 
complexation of diclofenac with 2, 3-dichloro-5, 
6-dicyano-1,4- benzoquinone (DDQ) has not 
been investigated. The rapid formation of 
intensely colored charge-transfer complexes has 
led to the use of π- acceptors such as DDQ in 
the development of visible spectrophotometric 
methods for analysis of many pharmaceutical 
compounds [16]. Since the alkali salts of 
carboxylic pharmaceutical compounds have 
been demonstrated to have excellent electron-
donating ability [17], we anticipated same for 
diclofenac sodium. The study investigated the 
charge-transfer complexation of diclofenac 
sodium with 2, 3-dichloro-5, 6-dicyano-1, 4-
benzoquinone. The thermodynamic parameters 




Reagents and apparatus 
 
Pure diclofenac sodium was a gift from Healthy 
Life Pharma, India. Diclofenac tablets and 
capsules were obtained from pharmacy shops 
and open market in Onitsha, Nigeria. Analytical 
grade of DDQ (Merck, Germany) and methanol 
(BDH, England) were used for the experiments. 
All absorption measurements were made on a 
computerized double-beam ultraviolet/visible 
Jenway 6505 spectrophotometer with matched 1 
cm quartz cuvette. Ohaus analytical balance 
(PA214), 10 ml pipettes, test tubes, measuring 
cylinder, beakers, glass funnels, 100 mL 
volumetric flask were also used in the 
experiments. 
  
Preparation of reagents 
 
A 100 mg of DDQ was accurately weighed using 
a Jenway analytical balance, dissolved with small 
volume of absolute methanol and made up to 
100 ml mark with the same solvent in a 
volumetric flask (1 mg/ml). A 22.7 ml of stock 
solution was diluted with 27.3 ml of absolute 
methanol to obtain a 0.002 M DDQ solution. 
  
To prepare a 0.002 M diclofenac sodium 
solution, 63.626 mg of diclofenac sodium was 
accurately weighed, dissolved with small volume 
of absolute methanol and made up to 100 ml 
mark with the same solvent in a volumetric flask 
(0.63626 mg/ml).  
 
Wavelength of maximum absorption 
 
A 2 ml diclofenac solution in methanol (0.002 M) 
was mixed with 2 ml of DDQ (0.002 M) and 
scanned between 200 and 800 nm wavelength at 
1 nm interval against a methanol solvent blank 
using Jenway 6505 computerized UV/Visible 
spectrophotometer. Similarly, diclofenac sodium 
(4 ml) and DDQ (4 ml) solutions in methanol 
were each also scanned spectrophometrically in 
the wavelength range of 250 - 400 nm 
wavelength against methanol solvent blank. 
Wavelengths of maximum absorption were 




The Job’s method of continuous variation was 
employed [21]. Master equimolar solutions (2 × 
10-3 M) of each of diclofenac and DDQ were 
prepared. Series of 10 ml portions of the master 
solutions of diclofenac with DDQ were made up 
comprising different complementary ratios (0:10, 
1:9, 9:1 and 10:0) in each of the test tubes. The 
reaction was allowed to proceed at room 
temperature (32 ± 1 °C) for 5 min. The 
absorbance values (in triplicate) of the different 
ratios were measured at 506 nm wavelength 
against blank cells treated similarly except 
methanol was used instead of diclofenac sample. 
The absorbance values were plotted as a 
function of diclofenac mole fraction. The molar 
ratio of diclofenac: DDQ was determined as the 




Freshly prepared diclofenac solution (0.002 M) 
was complexed with equal volume of freshly 
prepared DDQ (0.002 M) solution. The 
absorbance values of the mixtures were 
determined at 506 nm wavelength at intervals (0, 
2, 5, 10, 15, 20, 30, 40, 50, 60, 80, 100 mins, 2, 
3, 5, 7, 12 and 24 h) using the UV/Visible 
spectrophotometer. 
 
Effect of pH on complex formation 
 
Buffer solutions (pH 1, 3, 5, 7, 9, 11 and 13) were 
prepared. A 2 ml each of diclofenac solution 
(0.002 M) and DDQ solution (0.002 M) were 
mixed with 6 ml of the buffer solution. The 
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absorbance values of the resulting complexes 
were determined at 506 nm wavelength using the 
UV/Visible spectrophotometer. A graphical plot of 
the absorbance values against the pH was drawn 
using Microsoft Excel® tool pack.  The optimum 
pH range for complexation was determined from 
the graph plot. 
 
Determination of linearity 
 
A 1.2 ml of diclofenac sodium stock solution (2.0 
× 10-3 M) was complexed with 1.2 ml stock of 
DDQ (2.0 × 10-3 M) and the volume made up to 6 
ml with methanol affording a 21.11 mg %. Serial 
dilutions were made to afford 0.17 - 21.11 mg %. 
The absorbance values of the serial dilutions 
were determined after 60 min at 506 nm 
wavelength against methanol blank 
spectrophotometrically. A graphical plot of the 
absorbance values against the concentration 
afforded a calibration curve.  The slope and 
correlation coefficient of the linear plot were 
extracted from the graph.  
 
Evaluation of Beer’s law limit  
 
Concentrations of 0.002 M diclofenac sodium 
solution (0.00001, 0.0001, 0.001, 0.01, 0.1, 10, 
20, 40, 60, 80, 100, 120 mg %) were mixed with 
equal volumes of 0.002 M DDQ. The absorbance 
values of the formed complexes were determined 
after 60 min at 506 nm wavelength against the 
methanol solvent blank. A graphical plot of the 
absorbance values against concentration 
afforded a curve from which the Beer’s limit was 
estimated. 
 
Molar absorptivity, association constants and 
thermodynamic parameters 
 
Serial volumes (0.4, 0.8……2.4 ml) of a 0.002 M 
diclofenac solution were placed in different test 
tubes, diluted to 3 ml with methanol and each 
reacted with serial volumes (0.4, 0.8……2.4 ml) 
of 0.002 M DDQ solution. The contents were 
mixed, left at room temperature for 60 min and 
their absorbance values determined at 506 nm 
wavelength against a blank prepared 
simultaneously without diclofenac. Similarly, 
diclofenac and DDQ were reacted in a water bath 
at temperatures of 40, 50, 60 and 70 °C 
respectively. The molar absorptivity and 
association constant of the complexes obtained 
at different temperatures were calculated using 
Benesi-Hildebrand equation as in Eq 1 [18]. 
 
[Do][Ao]/AAD = {[Do]/εAD} + {1/[KADεAD]}………..(1) 
 
where [Do] and [Ao] are the initial concentration of 
the reactant species,  AAD is the absorbance of 
the complex,  εAD  is the molar absorptivity and 
KAD is the association constant. 
 
A graphical plot of [Do][Ao]/AAD  versus [Do] 
affords a straight line whose slope is equal to 
1/εAD and intercept is 1/[KADεAD]. 
  
The standard enthalpy change, ΔH°, of the 
interaction was calculated from the slope of the 
graphical plot of log K versus 1/T. The Gibbs free 
energy, ΔG°, for the respective complexes were 
obtained from Eq 2. 
 
ΔG° = -RTInKAD ………….…………………. (2) 
 
Consequently, the entropy, ΔS°, for the 
respective complexes were computed from Eq 3. 
 
ΔG° = ΔH° - TΔS° …………………….……. (3) 
 
Assay of diclofenac tablets and capsule 
 
Twenty tablets of each brand of diclofenac were 
individually weighed and the average weight for 
each brand calculated. Twenty tablets were 
powdered and the powdered sample equivalent 
to 100 mg of diclofenac sodium was transferred 
to 100 ml volumetric flask, made up to 100 ml 
volume with the methanol (100 mg %), vigorously 
shaken and filtered. The filtrate was thereafter 
made up to 100 ml with methanol. The filtrate 
(0.8 ml) was complexed with 0.8 ml of DDQ 
solution (2.0 × 10-2 M) in a test tube and the 
volume made up to 6 ml with methanol. The 
complexation was allowed to proceed for 60 min 
at room temperature and the absorbance value 
determined at 506 nm wavelength against a 
blank of methanol using the UV/Visible 
spectrophotometer. The assay of each brand 
was repeated thrice. Content of diclofenac 
sodium in each brand was estimated from the 




The limit of detection (LOD) and of quantitation 
(LOQ) were determined using the formula: LOD 
or LOQ = κSDa/b, where κ = 3 for LOD and 10 
for LOQ, SDa is the standard deviation and b is 





Accuracy of the proposed assay was assessed 
by recovery experiments using the standard 
addition method. Two different samples of 20 mg 
% of diclofenac complex were prepared and 
placed in a 100 ml volumetric flask. Two 
concentration (5 and 10 mg %) of pure diclofenac 
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sodium complex were prepared and respectively 
added to the  20 mg % complex, to afford  25 
and 30 mg % respectively. The mixtures were 
vigorously shaken and made up to 100 ml mark. 
The mixture (2 ml) was diluted with methanol to 
the 100 ml mark in a volumetric flask and the 
absorbance determined spectrophotometrically 
at 506 nm against methanol as blank, and 
percent recovery computed. 
  
Intra-day and inter-day precision 
 
Intra-day precision of the method was 
investigated by obtaining duplicate absorbance 
readings of ten different aliquots of a 2 mg % 
diclofenac complexed with 2 mg % DDQ at 506 
nm wavelength using UV/Visible 
spectrophotometer. The results were computed 
as in Eq 4.  
 
X1 –X2/(X1+X2)/2 …………………………….. (4)  
 
where X1 and X2 are the duplicate results from 
individual samples. 
 
The inter-day precision of the method was 
evaluated by analyzing the absorbance values of 
a freshly complexed 2 mg % of diclofenac in 
methanol with 2 mg % DDQ daily for five days. 
Duplicate absorbance readings of samples were 
obtained at 506 nm wavelength using UV/Visible 
spectrophotometer and investigated using the 
formula,  
 
X1 –X2/(X1+X2)/2,  
 





Various tablet excipients, lactose and starch 
(singly or mixed in different proportions), were 
mixed with freshly formed diclofenac complex 
respectively and their absorbance determined 
spectrophotometrically at 506 nm The results 





The results are expressed as mean ± standard 
error of mean (SEM) or as percentages, where 
applicable. Microsoft Excel® 2010 package was 




The result of the optical characteristics of 
diclofenac sodium complexed with DDQ is shown 
in Table 1. 
 
A 1:1 stoichiometric complex was formed 
between diclofenac sodium and DDQ as seen in 
the Job’s plot (Fig 1). 
 
 
Figure 1: Job’s plot for charge-transfer reaction of 
diclofenac with DDQ 
 
    Table 1: Optical characteristics of diclofenac: DDQ complex in absolute methanol 
 
Parameter Value 
 Wavelength                                        
Slope                                                  
Beer’s law limits                             
Regression equation                           
Correlation coefficient                      
Limit of detection                              
Limit of quantitation                          
Percentage recoveries                        
Inter-day precision (relative range)      
Intra-day precision (relative range)      
506 nm 
0.023 
0.0017 to 0.2111  mg/ml 
y= 0.0235x 
0.9977 ± 0.0010 
0.000801 mg/ml 
0.002426 mg/ml 
99.54 to 100.14 % 
0.0000 to 0.00163 
0.0000 to 0.00192 
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The investigation into the time-absorbance 
relationship of the diclofenac sodium and DDQ 
complex showed that even though the complex 
formation was spontaneous, no less than 60 min 
was required for the complexation reaction to 
come to completion. The formed complex was 
also found to be stable for over 24 h. The pH 
studies showed that the diclofenac: DDQ 
complex was favoured in the acidic region (pH, 1 
- 6). The pH of unbuffered complex was found to 
be 5.8. Beer’s plot for the diclofenac sodium and 
DDQ complex afforded a linear graph with high 
regression coefficient of 0.9977 as reported in 
Table 1. 
 
Good recovery results (> 99 %) were obtained 
from the selectivity experiments. Molar 
absorptivity and standard enthalpy change (ΔH°) 
of diclofenac: DDQ complex were 0.01 and -
61.85 kcal/deg/mol, respectively, at all the tested 
temperatures (303 to 343 K). Association 
constants of 220.0, 209.8, 206.0, 183.0 and 
174.6 were found for the diclofenac: DDQ 
complexes at 303, 313, 323, 333 and 343 K, 
respectively. Gibbs free energy change (ΔG°) 
and entropy change (ΔS°) for the respective 
complexes ranged from -103.29 to -98.86 and 
0.14938 to 0.09673 kcal/deg/mol respectively.  
 
The results of the identity profile and the assay of 
diclofenac brands using the proposed assay 




The result of the optical characteristics of 
diclofenac sodium complexed with DDQ as 
shown in Table 1 above confirms the formation of 
a charge transfer complex between diclofenac 
sodium and DDQ in methanol. Whereas 
diclofenac sodium in methanol itself shows 
maximum absorption at 357 nm wavelength, it 
was found to spontaneously form a blood-red 
complex with DDQ absorbing at 506 nm 
wavelength (visible region) of the 
electromagnetic region.  The formation of a 
blood-red colour on reaction of the yellow 
coloured DDQ solution and the colourless 
diclofenac sodium solution in methanol was 
suggestive of a charge transfer complex 
formation. This charge transfer complexation 
may be attributed to one or more of the three 
lone pairs electrons present in the drug molecule. 
It is thought that the carboxylate group of 
diclofenac contributed lone pairs of electrons 
which could extend the aromatic conjugation of 
diclofenac. These lone pairs of electrons are 
thought to have been donated to DDQ leading to 
the charge transfer complex formation evidenced 
by the bathochromic shift (357 to 506 nm).  
 
The stoichiometry of complex formation between 
diclofenac and DDQ was investigated using the 
Job’s method of continuous variation [18]. The 
result obtained is indicative of a strong electron 
donating center in the molecular structure of 
diclofenac sodium. The result obtained (1:1) also 
guided the choice of reacting ratio between 
diclofenac sodium and DDQ. 
 
Absorbance values obtained from complexation 
products may be variable if complexation is 
incomplete or the complex is unstable. In order to 
reduce this variability, we examined the time-
absorbance relationship of the formed complex.  
The result showed that complete complexation, 
which occurred from the sixtieth minute, was a 
necessary condition for absorbance 
measurements. Once the complex was 
completely formed, it remained stable for as long 
as 24 h. The implication of the long stability of 
the formed complex is that the proposed assay 
method will allow the analyst enough time for 
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analysis and that the proposed complexation 
method is a robust assay method. 
 
The investigation into the effect of pH on the 
diclofenac: DDQ complex formation showed that 
the use of a buffer system for optimum 
complexation of diclofenac sodium with DDQ 
was unnecessary. The pH of unbuffered complex 
(pH, 5.8) coincided with the optimum pH range 
(pH, 1 - 6) for complexation. It was deduced that 
the assay method developed from the 
complexation reaction may be minimally affected 
by the sample matrix. 
 
Our results showed that Beer’s law (linearity 
between concentration and absorbance) was 
obeyed by the formed complex in dilute solutions 
and that linearity was lost at high concentrations. 
This is consistent with the observation that 
absorbing species usually deviate from the 
Beer’s law at high concentrations. The high 
regression coefficient of 0.9977 was indicative of 
high linearity between the concentration of the 
complex and the absorbance values. This 
indicates that the proposed assay method is 
suitable for the intended assay. 
 
In order to understand the influence of tablet or 
capsule excipients on the accuracy of the 
proposed method, the selectivity experiments 
were done with lactose and starch. Lactose and 
starch are commonly used tablet excipients 
which may influence assay of active ingredients 
in formulations containing them. The 
investigation into the selectivity of the proposed 
complexation method showed minimal 
interference on the absorbance values of the 
complex as a result of the lactose and starch 
excipients added to the diclofenac and DDQ 
complexation matrix. This was inferred from the 
high percentage recoveries obtained in the 
experiment. 
 
The values (Table 1) obtained for the LOD, LOQ, 
percent recoveries, intra-day and inter-day 
precisions were considered acceptable for the 
intended assay. The near ten-fold difference 
between the LOD and LOQ is an indication of the 
high sensitivity of the proposed complexation 
assay method. Near 100 % recovery values 
confirmed the accuracy of the proposed assay 
method. Minimal relative changes as obtained 
from intra-day and inter-day precision 
experiments show that the proposed assay 
method would be robust for the intended 
application. 
 
The negative Gibbs free energy change (ΔG°) 
and positive entropy change (ΔS°) obtained for 
diclofenac: DDQ complexes are consistent with 
expected thermodynamic parameters for a 
spontaneous reaction. Both ΔG° and ΔS° were 
dependent on temperatures of complexation. 
While ΔG° increased with increasing 
temperature, ΔS° decreased with increasing 
temperature, suggesting decreased spontaneity 
as temperatures of complexation are elevated. 
The molar absorptivity and ΔS° were found to be 
constant and independent of temperatures of 
complexation. Results obtained from the assay of 
commercial samples of diclofenac tablets and 
capsule brands further confirm the practicality of 




Charge-transfer complexation of diclofenac with 
2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone 
provides a suitable, simple and robust method for 
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